{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:31:25Z","timestamp":1793802685562,"version":"4.6.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R00AG071742"],"award-info":[{"award-number":["R00AG071742"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["32370711"],"award-info":[{"award-number":["32370711"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between subclinical cardiovascular disease (CVD) and cognitive decline in hypertensive adults and the underlying brain pathologies remain unclear. It is also undetermined whether intensifying blood pressure (BP) treatment slows down cognitive decline associated with subclinical CVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a post hoc analysis of the Systolic Blood Pressure Intervention Trial. Subclinical CVD at baseline was identified by elevated levels of high-sensitivity cardiac troponin T (hs-cTnT\u2005\u2265\u200514\u00a0ng\/L) and N-terminal pro-B-type natriuretic peptide (NT-proBNP\u2005\u2265\u2005125 pg\/mL). Global cognitive function and domain-specific measures (memory, processing speed, language, and executive function) were assessed at baseline and follow-up (years 2, 4, and 6) in 2\u00a0733 participants. White matter lesions, cerebral blood flow, and brain tissue volume were assessed by MRI at baseline and year 4 in a subset of 639 participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both elevated hs-cTnT and NT-proBNP levels at baseline were associated with accelerated cognitive decline across all domains after adjusting for potential confounding factors. The group with elevated levels of both cardiac biomarkers showed the fastest decline, with a larger annual decline rate of 0.033 (95% CI: 0.024\u20130.041) in the z-score of global cognitive function compared with\u00a0the group with normal levels. Elevated levels of both biomarkers were also associated with a faster progression in white matter lesions, but not with changes in total brain tissue volume or cerebral blood flow. Intensive BP treatment did not attenuate these associations compared with standard treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Subclinical CVD may contribute to faster white matter lesion progression and accelerated cognitive decline in patients with hypertension, regardless of intensive BP treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/gerona\/glaf005","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T15:18:13Z","timestamp":1736263093000},"source":"Crossref","is-referenced-by-count":4,"title":["Cardiac Biomarkers, Subclinical Brain Vascular Changes, and Cognitive Decline: Post Hoc Analysis of the SPRINT Trial"],"prefix":"10.1093","volume":"80","author":[{"given":"Wenxin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon B","family":"Ascher","sequence":"additional","affiliation":[{"name":"Kidney Health Research Collaborative, Department of Medicine, San Francisco Veterans Affairs Health Care System and University of California San Francisco , San Francisco, California ,","place":["USA"]},{"name":"Division of Hospital Medicine, University of California Davis , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Dolui","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya M","family":"Nasrallah","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital , New Haven, Connecticut ,","place":["USA"]},{"name":"Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine , New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Neitzel","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre , Rotterdam ,","place":["The Netherlands"]},{"name":"Department of Epidemiology, Erasmus MC, University Medical Centre , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Toledo","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, University of Navarra, Instituto de Investigaci\u00f3n Sanitaria de Navarra (IdiSNA) ,\u00a0 Pamplona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Glodzik","sequence":"additional","affiliation":[{"name":"Department of Radiology, Brain Health Imaging Institute, Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam A","family":"Shaltout","sequence":"additional","affiliation":[{"name":"Hypertension and Vascular Research Center, Wake Forest University School of Medicine , Winston-Salem, North Carolina ,","place":["USA"]},{"name":"Department of Epidemiology and Prevention, Wake Forest University School of Medicine , Winston-Salem, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Wake Forest University School of Medicine , Winston-Salem, North Carolina ,","place":["USA"]},{"name":"Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine , Winston-Salem, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarett D","family":"Berry","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical School , Dallas, Texas , (Medical Sciences Section)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2025060705251815000_CIT0001","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA."},{"key":"2025060705251815000_CIT0002","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-56782-2_497-2","article-title":"Small vessel ischemic disease","volume-title":"Encyclopedia of Clinical Neuropsychology","author":"Neirmeyer","year":"2017"},{"key":"2025060705251815000_CIT0003","doi-asserted-by":"publisher","first-page":"1095236","DOI":"10.3389\/fepid.2023.1095236","article-title":"Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses","volume":"3","author":"Brain","year":"2023","journal-title":"Front Epidemiol"},{"key":"2025060705251815000_CIT0004","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/jamaneurol.2016.5335","article-title":"Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts","volume":"74","author":"Hilal","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025060705251815000_CIT0005","doi-asserted-by":"publisher","first-page":"abn6598","DOI":"10.1126\/science.abn6598","article-title":"Heart-brain connections: phenotypic and genetic insights from magnetic resonance images","volume":"380","author":"Zhao","year":"2023","journal-title":"Science."},{"key":"2025060705251815000_CIT0006","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jalz.2016.09.004","article-title":"Hemodynamic and serum cardiac markers and risk of cognitive impairment and dementia","volume":"13","author":"van der Velpen","year":"2017","journal-title":"Alzheimers Dement."},{"key":"2025060705251815000_CIT0007","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00415-016-8378-7","article-title":"High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer\u2019s disease: the FINRISK Study","volume":"264","author":"Tynkkynen","year":"2017","journal-title":"J Neurol."},{"key":"2025060705251815000_CIT0008","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2337\/dc12-2241","article-title":"Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes","volume":"36","author":"Feinkohl","year":"2013","journal-title":"Diabetes Care."},{"key":"2025060705251815000_CIT0009","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/alz.12926","article-title":"Circulating cardiac biomarkers, structural brain changes, and dementia: emerging insights and perspectives","volume":"19","author":"Jensen","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025060705251815000_CIT0010","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1161\/STROKEAHA.120.032571","article-title":"Blood-based cardiac biomarkers and the risk of cognitive decline, cerebrovascular disease, and clinical events","volume":"52","author":"Gyanwali","year":"2021","journal-title":"Stroke."},{"key":"2025060705251815000_CIT0011","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/2047487316632364","article-title":"High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk","volume":"23","author":"Wijsman","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2025060705251815000_CIT0012","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ana.24203","article-title":"N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk","volume":"76","author":"Wijsman","year":"2014","journal-title":"Ann Neurol."},{"key":"2025060705251815000_CIT0013","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11357-020-00202-3","article-title":"Patterns of multi-domain cognitive aging in participants of the long life family study","volume":"42","author":"Sebastiani","year":"2020","journal-title":"Geroscience"},{"key":"2025060705251815000_CIT0014","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00330-016-4450-z","article-title":"Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer\u2019s disease","volume":"27","author":"Benedictus","year":"2017","journal-title":"Eur Radiol."},{"key":"2025060705251815000_CIT0015","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/jcbfm.2015.121","article-title":"Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons","volume":"36","author":"Abraham","year":"2016","journal-title":"J Cereb Blood Flow Metab."},{"key":"2025060705251815000_CIT0016","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/hr.2009.100","article-title":"Relationship between cerebral blood flow and later cognitive decline in hypertensive patients with cerebral small vessel disease","volume":"32","author":"Kitagawa","year":"2009","journal-title":"Hypertens Res."},{"key":"2025060705251815000_CIT0017","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1212\/01.wnl.0000280577.43413.d9","article-title":"Trajectories of brain loss in aging and the development of cognitive impairment","volume":"70","author":"Carlson","year":"2008","journal-title":"Neurology."},{"key":"2025060705251815000_CIT0018","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fneur.2018.00307","article-title":"N-terminal pro-brain natriuretic peptide and associations with brain magnetic resonance imaging (MRI) features in middle age: the CARDIA Brain MRI Study","volume":"9","author":"Ferguson","year":"2018","journal-title":"Front Neurol."},{"key":"2025060705251815000_CIT0019","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1161\/ATVBAHA.118.311082","article-title":"Cross-sectional associations between cardiac biomarkers, cognitive performance, and structural brain changes are modified by age","volume":"38","author":"Veugen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2025060705251815000_CIT0020","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1212\/WNL.0000000000001885","article-title":"N-terminal pro-brain natriuretic peptide and abnormal brain aging","volume":"85","author":"Sabayan","year":"2015","journal-title":"Neurology."},{"key":"2025060705251815000_CIT0021","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA."},{"key":"2025060705251815000_CIT0022","doi-asserted-by":"publisher","first-page":"e023314","DOI":"10.1161\/JAHA.121.023314","article-title":"Associations of high-sensitivity troponin and natriuretic peptide levels with serious adverse events in SPRINT","volume":"11","author":"Ascher","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025060705251815000_CIT0023","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamacardio.2021.3187","article-title":"Associations of high-sensitivity troponin and natriuretic peptide levels with outcomes after intensive blood pressure lowering: findings from the SPRINT randomized clinical trial","volume":"6","author":"Berry","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2025060705251815000_CIT0024","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the systolic blood pressure intervention trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials."},{"key":"2025060705251815000_CIT0025","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"The SPRINT Research Group","year":"2015","journal-title":"N Engl J Med."},{"key":"2025060705251815000_CIT0026","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jama.2019.10551","article-title":"Association of intensive vs standard blood pressure control with cerebral white matter lesions","volume":"322","author":"The SPRINT MIND Investigators for the SPRINT Research Group","year":"2019","journal-title":"JAMA."},{"key":"2025060705251815000_CIT0027","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S1474-4422(20)30319-7","article-title":"Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial","volume":"19","author":"Rapp","year":"2020","journal-title":"Lancet Neurol."},{"key":"2025060705251815000_CIT0028","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jamaneurol.2022.0074","article-title":"Association of intensive vs standard blood pressure control with cerebral blood flow: secondary analysis of the SPRINT MIND randomized clinical trial","volume":"79","author":"Dolui","year":"2022","journal-title":"JAMA Neurol"},{"key":"2025060705251815000_CIT0029","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2021.0178","article-title":"Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND randomized trial","volume":"78","author":"Nasrallah","year":"2021","journal-title":"JAMA Neurol"},{"key":"2025060705251815000_CIT0030","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/hec.4510","article-title":"Linear mixed models to handle missing at random data in trial-based economic evaluations","volume":"31","author":"Gabrio","year":"2022","journal-title":"Health Econ."},{"key":"2025060705251815000_CIT0031","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/JAD-170171","article-title":"High sensitivity cardiac troponin t and cognitive function in the oldest old: the Leiden 85-Plus Study","volume":"60","author":"Bertens","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"2025060705251815000_CIT0032","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jnnp-2014-309968","article-title":"The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population","volume":"87","author":"Mirza","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"2025060705251815000_CIT0033","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/eurheartj\/ehu124","article-title":"High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study","volume":"35","author":"Schneider","year":"2014","journal-title":"Eur Heart J."},{"key":"2025060705251815000_CIT0034","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1161\/STROKEAHA.119.028410","article-title":"High-sensitivity cardiac troponin t and cognitive function in patients with ischemic stroke","volume":"51","author":"Broersen","year":"2020","journal-title":"Stroke."},{"key":"2025060705251815000_CIT0035","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/jgs.16092","article-title":"High-sensitive troponin T, natriuretic peptide, and cognitive change","volume":"67","author":"Pokharel","year":"2019","journal-title":"J Am Geriatr Soc."},{"key":"2025060705251815000_CIT0036","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/HYPERTENSIONAHA.124.22876","article-title":"High-sensitivity troponin T, NT-proBNP, and cognitive outcomes in SPRINT","volume":"81","author":"Haney","year":"2024","journal-title":"Hypertension."},{"key":"2025060705251815000_CIT0037","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.neuroimage.2009.09.052","article-title":"Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging","volume":"49","author":"Kochunov","year":"2010","journal-title":"Neuroimage."},{"key":"2025060705251815000_CIT0038","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/STROKEAHA.110.600940","article-title":"Regional ischemic vulnerability of the brain to hypoperfusion","volume":"42","author":"Payabvash","year":"2011","journal-title":"Stroke."},{"key":"2025060705251815000_CIT0039","doi-asserted-by":"publisher","first-page":"108","DOI":"10.14283\/jpad.2023.64","article-title":"Modifiable risk factors for accelerated decline in processing speed: results from three dutch population cohorts","volume":"11","author":"Jaarsma","year":"2023","journal-title":"J Prev Alzheimers Dis."},{"key":"2025060705251815000_CIT0040","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1212\/WNL.0000000000000820","article-title":"NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study","volume":"83","author":"van Vliet","year":"2014","journal-title":"Neurology."},{"key":"2025060705251815000_CIT0041","doi-asserted-by":"publisher","first-page":"617705","DOI":"10.3389\/fcvm.2020.617705","article-title":"Gender-related differences in heart failure biomarkers","volume":"7","author":"Cediel","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025060705251815000_CIT0042","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1161\/STROKEAHA.113.001128","article-title":"Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study","volume":"44","author":"Dadu","year":"2013","journal-title":"Stroke."},{"key":"2025060705251815000_CIT0043","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2024.11.006","article-title":"Cerebral white matter hyperintensity volumes: normative age- and sex-specific values from 15 population-based cohorts comprising 14\u2005876 individuals","volume":"146","author":"de Kort","year":"2025","journal-title":"Neurobiol Aging."},{"key":"2025060705251815000_CIT0044","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ."},{"key":"2025060705251815000_CIT0045","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1531-8249(200002)47:2&lt;145::aid-ana3&gt;3.3.co;2-g","article-title":"Cerebral white matter lesions and cognitive function: the Rotterdam scan study","volume":"47","author":"Cees De Groot","year":"2000","journal-title":"Ann Neurol."},{"key":"2025060705251815000_CIT0046","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuroimage.2008.03.057","article-title":"Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies","volume":"42","author":"Turken","year":"2008","journal-title":"Neuroimage."},{"key":"2025060705251815000_CIT0047","first-page":"99","article-title":"B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide\u2014diagnostic role in stable coronary artery disease","volume":"11","author":"Weber","year":"2006","journal-title":"Exp Clin Cardiol"},{"key":"2025060705251815000_CIT0048","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation."},{"key":"2025060705251815000_CIT0049","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00429-015-1097-5","article-title":"Brain white matter structure and information processing speed in healthy older age","volume":"221","author":"Kuznetsova","year":"2016","journal-title":"Brain Struct Funct."},{"key":"2025060705251815000_CIT0050","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","article-title":"Hypertension-induced cognitive impairment: from pathophysiology to public health","volume":"17","author":"Ungvari","year":"2021","journal-title":"Nat Rev Nephrol."}],"container-title":["The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glaf005\/61381579\/glaf005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/80\/6\/glaf005\/63448574\/glaf005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/80\/6\/glaf005\/63448574\/glaf005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T05:25:25Z","timestamp":1749273925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/doi\/10.1093\/gerona\/glaf005\/7945661"}},"subtitle":[],"editor":[{"given":"Roger A","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glaf005","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,8]]},"article-number":"glaf005"}}